We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Risk Assessment and Treat Compliance in Hypertension Education Trial (RATCHET)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00694239
First Posted: June 10, 2008
Last Update Posted: June 30, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
University of Western Ontario, Canada
The Physicians' Services Incorporated Foundation
Information provided by:
Lawson Health Research Institute
June 6, 2008
June 10, 2008
June 30, 2011
May 2007
March 2011   (Final data collection date for primary outcome measure)
Medication Compliance [ Time Frame: 1 year ]
Same as current
Complete list of historical versions of study NCT00694239 on ClinicalTrials.gov Archive Site
  • Patient perception of cardiovascular risk [ Time Frame: 1 year ]
  • Pilot Feasibility Study [ Time Frame: 1 year ]
  • Blood Pressure [ Time Frame: 1 year ]
  • Cholesterol Level [ Time Frame: 1 year ]
  • Framingham Risk Score (stroke and coronary artery disease) [ Time Frame: 1 year ]
Same as current
Not Provided
Not Provided
 
Risk Assessment and Treat Compliance in Hypertension Education Trial
Evaluation of the Effect of Cardiovascular Risk Assessment in Treatment Compliance in Hypertension
The RATCHET study assesses if patient knowledge of estimated cardiovascular risk at current and recommended target blood pressure levels improves compliance in the management of hypertension.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
  • Hypertension
  • Dyslipidemia
Behavioral: Knowledge of Cardiovascular Risk Assessment
Knowledge of Cardiovascular Risk Assessment and risk reduction at target BP, reviewed every 3-6 months.
  • No Intervention: B
    Standard Care
  • Experimental: A
    Risk Assessment plus standard care
    Intervention: Behavioral: Knowledge of Cardiovascular Risk Assessment
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
100
March 2011
March 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Essential hypertension (new diagnosis or established diagnosis) meeting criteria for pharmacologic therapy as defined by current guidelines

Exclusion Criteria:

  • Lack of written informed consent
  • Previous myocardial infarction
  • Previous stroke
  • Congestive heart failure
  • Stage 3 or greater chronic kidney disease
  • Pregnancy
  • Usage of medication bubble/blister package
Sexes Eligible for Study: All
30 Years to 84 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Canada
 
 
NCT00694239
R-07-053
13014E ( Other Identifier: REB )
Yes
Not Provided
Not Provided
George Dresser, University of Western Ontario
Lawson Health Research Institute
  • University of Western Ontario, Canada
  • The Physicians' Services Incorporated Foundation
Principal Investigator: Bryan J Har, MD University of Western Ontario, Canada
Principal Investigator: George K Dresser, PhD, MD University of Western Ontario, Canada
Lawson Health Research Institute
June 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP